Tencent, Medopad in medical AI deal

Tencent Holdings Ltd. (HKSE:0700) and Medopad Ltd. (London, U.K.) partnered to jointly develop AI-enabled healthcare technologies including a clinical decision support system, online doctor consultations and medical chatbots. The collaboration will utilize Tencent's AI technology and Medopad's mobile medical applications.

Last week, Tencent -- which operates China's main instant messenger app WeChat -- and AstraZeneca plc (LSE:AZN; NYSE:AZN) announced a partnership to utilize Tencent's big data capabilities to address the prevalence of counterfeit and substandard medicines in China...